SCHEMBL2276033

SCHEMBL2276033

O=S(=O)(c1ccccc1)n1ccc2c3c(cnc21)ncn3C1CCC(N2CCOCC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 7/20 0.53
ACVR1 Q04771 3/20 0.37
BMPR1B O00238 1/20 0.37
BMPR1A P36894 1/20 0.37
ACVR1B P36896 1/20 0.37
TGFBR1 P36897 1/20 0.37
HSD11B1 P28845 1/20 0.37
JAK2 O60674 2/20 0.36
TYK2 P29597 2/20 0.36
JAK3 P52333 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTT P42858 1/20 0.36
GAA P10253 1/20 0.35
MAOB P27338 1/20 0.35
HTR6 P50406 1/20 0.35
HPGD P15428 1/20 0.35
USP5 P45974 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2280883 0.89 HTT (0.50) JAK1ALDH1A1SMN1; SMN2HTTCYP2C19
SCHEMBL2274818 0.86 JAK1 (0.46) JAK1SMN1; SMN2HTTMAOBHTR6
SCHEMBL2223730 0.85 JAK1 (0.53) JAK1JAK2TYK2JAK3CYP2C19
SCHEMBL2226057 0.85 JAK1 (0.51) JAK1JAK2TYK2JAK3HTR6
SCHEMBL2279026 0.85 JAK1 (0.52) JAK1JAK2TYK2JAK3ALDH1A1
SCHEMBL2276333 0.85 JAK1 (0.52) JAK1JAK2TYK2JAK3HTR6
SCHEMBL2273246 0.84 JAK1 (0.52) JAK1JAK2TYK2JAK3CYP2C19
SCHEMBL2223327 0.84 JAK1 (0.53) JAK1JAK2TYK2JAK3MAOB
SCHEMBL2283215 0.83 JAK1 (0.46) JAK1JAK2TYK2JAK3HTR6
SCHEMBL2270971 0.83 JAK1 (0.48) JAK1JAK2TYK2JAK3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed